title: Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.
abstract: To determine the minimum vaccine potency per intradermal dose required to elicit an adequate immune response using the Thai Red Cross (TRC) regimen (2-2-2-0-1-1), healthy volunteers received 0.1 mL volumes of PCECV containing decreasing amounts of antigen. Subjects also received HRIG to evaluate potential interference with antibody production. Results indicated that when each 0.1 mL intradermal dose of PCECV contained antigen corresponding to 0.32 IU per intramuscular dose, every subject had titers above 0.5 IU/mL by day 14. These results confirm that the current World Health Organization (WHO) recommendations for vaccine potency (2.5 IU per intramuscular dose) are sufficient for use in the Thai Red Cross intradermal regimen.
authors.affiliation: Department of Infectious Diseases, University Hospital, Hradec Kralove, Czech Republic.
authors.forename: Jiri
authors.initials: J
authors.lastname: Beran
authors.forename: Karel
authors.initials: K
authors.lastname: Honegr
authors.forename: Angelika
authors.initials: A
authors.lastname: Banzhoff
authors.forename: Claudius
authors.initials: C
authors.lastname: Malerczyk
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis / Q000096:biosynthesis; D001681:Biological Assay; D002642:Chick Embryo; D002522:Chlorocebus aethiops; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007271:Injections, Intradermal; D011818:Rabies / Q000276:immunology / Q000517:prevention & control; D011819:Rabies Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology; D014709:Vero Cells
chemical_list: D000914:Antibodies, Viral; D007136:Immunoglobulins; D011819:Rabies Vaccines; D014614:Vaccines, Synthetic